CRONUS PHARMA

Serial Number 86305431
Registration 5064672
702

Registration Progress

Application Filed
Jun 10, 2014
Under Examination
Jan 20, 2015
Approved for Publication
Nov 25, 2014
Published for Opposition
Nov 25, 2014
Registered
Oct 18, 2016

Basic Information

Serial Number
86305431
Registration Number
5064672
Filing Date
June 10, 2014
Registration Date
October 18, 2016
Published for Opposition
November 25, 2014
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Oct 10, 2023
Registration
Registered
Classes
035 042

Rights Holder

Cronus Pharma LLC

16
Address
2 Tower Center Blvd, Suite 1101A
East Brunswick, NJ 08816

Ownership History

Cronus Pharma

Original Applicant
16
East Brunswick, NJ

Cronus Pharma LLC

Owner at Publication
16
East Brunswick, NJ

Cronus Pharma LLC

Original Registrant
16
East Brunswick, NJ

Legal Representation

Attorney
Harry B. Ray

USPTO Deadlines

Next Deadline
466 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-10-18)
Due Date
October 18, 2026
Grace Period Ends
April 18, 2027

Application History

45 events
Date Code Type Description
Oct 10, 2023 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Oct 10, 2023 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 10, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 7, 2023 E815 I TEAS SECTION 8 & 15 RECEIVED
Oct 18, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 1, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 1, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 18, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER
Sep 15, 2016 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 14, 2016 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 29, 2016 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Aug 19, 2016 IUAF S USE AMENDMENT FILED
Aug 19, 2016 EISU I TEAS STATEMENT OF USE RECEIVED
Aug 15, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 15, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 8, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 7, 2016 EX3G S SOU EXTENSION 3 GRANTED
May 20, 2016 EXT3 S SOU EXTENSION 3 FILED
May 20, 2016 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 17, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 16, 2016 EX2G S SOU EXTENSION 2 GRANTED
Feb 12, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 10, 2016 EXT2 S SOU EXTENSION 2 FILED
Jan 10, 2016 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 8, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 6, 2015 EX1G S SOU EXTENSION 1 GRANTED
Jul 6, 2015 EXT1 S SOU EXTENSION 1 FILED
Jul 6, 2015 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 20, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 25, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2014 PUBO A PUBLISHED FOR OPPOSITION
Nov 5, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 22, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 14, 2014 ALIE A ASSIGNED TO LIE
Sep 26, 2014 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 24, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2014 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2014 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2014 GNRT F NON-FINAL ACTION E-MAILED
Sep 23, 2014 CNRT R NON-FINAL ACTION WRITTEN
Sep 19, 2014 DOCK D ASSIGNED TO EXAMINER
Jun 20, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 13, 2014 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 035
First Use Anywhere: Jul 1, 2016
First Use in Commerce: Jul 1, 2016
Class 042
First Use Anywhere: Jul 1, 2016
First Use in Commerce: Jul 1, 2016

Classification

International Classes
035 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"